Product Information

CHOLESTYRAMINE POWDER is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0979 per GM under NDC 68382052842. Its NADAC has been published 408 times since Nov 7, 2018.

FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHOLESTYRAMINE POWDER

CHOLESTYRAMINE
$0.0979per GM

Strength

4 g/9g

NDC

68382052842

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202901

FDA Approved

7/2/2018

TE Code

AB

On Market Since

8/1/2018

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for CHOLESTYRAMINE POWDER has been published 408 times since Nov 7, 2018, and over the history we have for it it has declined 44.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0979 per GM
All-time high$0.1965 (Sep 16, 2020)
All-time low$0.0789 (Nov 20, 2024)
52-week high$0.0979
52-week low$0.0916
Median price$0.1404
Average price$0.1402
Largest weekly change+61.2% (May 22, 2024)
Weeks tracked408
Tracking sinceNov 7, 2018

Price History

1W

+2.7%

1M

+6.0%

3M

+3.5%

6M

+3.3%

1Y

+11.8%

3Y

-8.7%

5Y

-36.6%

All

-44.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CHOLESTYRAMINE POWDER?

The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE POWDER, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0979 per GM (NDC 68382052842), effective Nov 18, 2026.

How has the price of CHOLESTYRAMINE POWDER changed over time?

Over the history we have for it, the NADAC for CHOLESTYRAMINE POWDER has declined 44.2%. It has been tracked across 408 weekly CMS publications since Nov 7, 2018.

What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE POWDER?

Since Nov 7, 2018, the NADAC for CHOLESTYRAMINE POWDER has ranged from a low of $0.0789 (Nov 20, 2024) to a high of $0.1965 (Sep 16, 2020), with a median of $0.1404 per GM.

Are there cheaper alternatives to CHOLESTYRAMINE POWDER?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE POWDER in a comparable dosage form, but none are currently priced below it.

Who manufactures CHOLESTYRAMINE POWDER?

CHOLESTYRAMINE POWDER (NDC 68382052842) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.